NRSN
NeuroSense Therapeutics Ltd.Company with tickers: NRSN, NRSNW
CIK
1875091
CUSIP
M74240108
Shares Outstanding
36,099,813
13F Activity (30d)
11 filings
11 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $6,227,000 | USD | 2025-12-31 | 20-F | 2026-03-31 |
| Operating Income | $-11,085,000 | USD | 2025-12-31 | 20-F | 2026-03-31 |
| Net Income | $-11,125,000 | USD | 2025-12-31 | 20-F | 2026-03-31 |
| EPS (Basic) | $-0.44 | USD/shares | 2025-12-31 | 20-F | 2026-03-31 |
| EPS (Diluted) | $-0.44 | USD/shares | 2025-12-31 | 20-F | 2026-03-31 |